X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (283) 283
female (258) 258
index medicus (255) 255
oncology (241) 241
breast cancer (191) 191
middle aged (151) 151
breast neoplasms - pathology (145) 145
adult (129) 129
aged (116) 116
breast neoplasms - drug therapy (108) 108
cancer (100) 100
prognosis (100) 100
article (90) 90
breast neoplasms - genetics (70) 70
chemotherapy (69) 69
breast neoplasms - metabolism (68) 68
survival (68) 68
treatment outcome (65) 65
research (61) 61
aged, 80 and over (56) 56
breast neoplasms - mortality (55) 55
retrospective studies (55) 55
disease-free survival (52) 52
cell biology (50) 50
neoplasm staging (50) 50
care and treatment (49) 49
trastuzumab (47) 47
mutation (46) 46
therapy (46) 46
receptor, erbb-2 - metabolism (44) 44
carcinoma (41) 41
neoadjuvant therapy (41) 41
tumors (40) 40
animals (39) 39
chemotherapy, adjuvant (38) 38
receptors, estrogen - metabolism (38) 38
women (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (37) 37
breast neoplasms - therapy (37) 37
expression (36) 36
cell line, tumor (34) 34
antineoplastic agents - therapeutic use (33) 33
medicine & public health (33) 33
adjuvant chemotherapy (32) 32
genetic aspects (32) 32
health aspects (32) 32
metastasis (30) 30
neoadjuvant chemotherapy (30) 30
risk factors (30) 30
abridged index medicus (29) 29
analysis (29) 29
gene expression (29) 29
hematology, oncology and palliative medicine (28) 28
risk (28) 28
paclitaxel (27) 27
receptors, progesterone - metabolism (27) 27
recurrence (27) 27
survival rate (27) 27
mice (26) 26
breast neoplasms - surgery (25) 25
follow-up studies (25) 25
gene expression profiling (25) 25
doxorubicin (24) 24
proportional hazards models (24) 24
settore med/27 - neurochirurgia (24) 24
surgery (24) 24
kaplan-meier estimate (23) 23
lymphatic metastasis (23) 23
patient outcomes (23) 23
survival analysis (23) 23
breast neoplasms - chemistry (22) 22
breast neoplasms - diagnosis (22) 22
cancer patients (22) 22
estrogen-receptor (22) 22
gene expression regulation, neoplastic (22) 22
biomarkers, tumor - metabolism (21) 21
breast-cancer (21) 21
cells (21) 21
preoperative chemotherapy (21) 21
diagnosis (20) 20
drug therapy (20) 20
gene-expression (20) 20
growth (20) 20
immunohistochemistry (20) 20
male (20) 20
skin and connective tissue diseases (20) 20
young adult (20) 20
biology (19) 19
combined modality therapy (19) 19
estrogen (19) 19
mastectomy (19) 19
medicine (19) 19
tumor (19) 19
adjuvant treatment (18) 18
biochemistry & molecular biology (18) 18
her2 (18) 18
receptor, erbb-2 - analysis (18) 18
research article (18) 18
resistance (18) 18
cancer research (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. LB-37 - LB-37
Journal Article
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 10/2013, Volume 11, Issue 10 Supplement, pp. PR05 - PR05
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 8, pp. 1275 - 1281
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2010, Volume 120, Issue 7, pp. 2406 - 2413
Journal Article
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 02/2019, Volume 18, Issue 2, pp. 399 - 412
There is compelling evidence that oncogenic MET and PIK3CA signaling pathways contribute to breast cancer. However, the activity of pharmacologic targeting of... 
CABOZANTINIB | PROTEIN-LEVELS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | C-MET | DOUBLE-BLIND | FACTOR EXPRESSION | PHASE-II | MUTATIONS | IDENTIFICATION | FACTOR RECEPTOR
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 392 - 392
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2012, Volume 18, Issue 7, pp. 1052 - 1059
Neoadjuvant chemotherapy (NAC) induces a pathological complete response (pCR) in similar to 30% of patients with breast cancer. However, many patients have... 
MEDICINE, RESEARCH & EXPERIMENTAL | STEM-CELLS | METASTASIS | PREDICTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | CELL BIOLOGY | EPITHELIAL-MESENCHYMAL TRANSITION | MEK | INHIBITION | GENE-EXPRESSION | RECURRENCE | KI67 | Tissue Banks | Humans | Gene Expression Regulation, Neoplastic | ras Proteins - metabolism | Ki-67 Antigen - metabolism | Gene Expression Profiling | Extracellular Signal-Regulated MAP Kinases - metabolism | RNA, Messenger - metabolism | Gene Knockdown Techniques | Neoplasm, Residual | Paraffin Embedding | Mitogen-Activated Protein Kinase Kinases - metabolism | Breast Neoplasms - enzymology | MAP Kinase Signaling System - genetics | Dual-Specificity Phosphatases - genetics | Female | Neoadjuvant Therapy | Tissue Fixation | Genes, Neoplasm - genetics | Breast Neoplasms - classification | Cell Survival | Dual-Specificity Phosphatases - metabolism | RNA, Messenger - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Mitogen-Activated Protein Kinase Phosphatases - deficiency | Treatment Outcome | Breast Neoplasms - drug therapy | Mitogen-Activated Protein Kinase Phosphatases - genetics | Dual-Specificity Phosphatases - deficiency | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Mice | Enzyme Activation | Apoptosis | Mitogen-Activated Protein Kinase Phosphatases - metabolism | Adjuvant treatment | Breast cancer | Research | Drug resistance | Drug therapy | Health aspects | Cancer | Chemotherapy
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2010, Volume 107, Issue 22, pp. 10208 - 10213
PIK3CA mutations are reported to be present in approximately 25% of breast cancer (BC), particularly the estrogen receptor—positive (ER+) and... 
Datasets | Health outcomes | Prognosis | Cell lines | Breast cancer | Signatures | Gene expression | Genetic mutation | Tumors | Cancer | Gene expression profiling | PI3 kinase | MOLECULAR SUBTYPES | TYROSINE PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | PTEN | 3-KINASE MUTATIONS | AKT | EXPRESSION PROFILES | TUMORS | INSULIN-RECEPTOR | PATHWAY | POOR-PROGNOSIS | gene expression profiling | Neoplasms, Hormone-Dependent - metabolism | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Multiprotein Complexes | Receptor, ErbB-2 - metabolism | DNA Primers - genetics | Gene Expression Profiling | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Mechanistic Target of Rapamycin Complex 1 | Neoplasms, Hormone-Dependent - genetics | Proteins | Antineoplastic Agents, Hormonal - therapeutic use | Base Sequence | Female | Sirolimus - therapeutic use | Signal Transduction | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Transcription Factors - metabolism | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Antibiotics, Antineoplastic - therapeutic use | Tamoxifen - therapeutic use | Cell Line, Tumor | TOR Serine-Threonine Kinases | Mutation | Neoplasms, Hormone-Dependent - drug therapy | Receptors | Analysis | Estrogen | Genetic aspects | Research | Properties | Tamoxifen | Protein kinases | Health aspects | TOR protein | Transformation | Exons | Estrogens | AKT protein | Data processing | 1-Phosphatidylinositol 3-kinase | Signal transduction | Biological Sciences
Journal Article